Based on your detailed feedback, we may suggest: Splitting the full dose into two smaller injections spaced apart
"Health Canada won't approve it as a drug, but it slips through as a compounded natural health product, where the federal safety check basically doesn't happen." Health Canada considers NHP compounding within a practitioner-patient relationship distinct from manufacturing and not subject to the same regulatory oversight
That produces 6.67 mg/mL, where a 500 mcg dose is 7.5 units and 1,000 mcg is 15 units
The right option depends on the patients symptoms, goals, safety needs, and provider recommendation
Theres also AOD 9604, a growth hormone fragment peptide, being promoted for the same claims